Traditional treatments like Anthracyclines used in treatment of Lymphoma can lead to Left ventricular Systolic Dysfunction whereas Bruton Tyrosine Kinase Inhibitors are associated with arterial and ventricular arrhythmias.
Newer treatments like immunotherapy are associated with myocarditis which has high fatality rates & cardiovascular issues arising of CART cell therapy are often attributed to Cytokine Release Syndrome (CRS).
Author suggests: identification of high-risk patients, modifying risk factors, quick intervention, assessment of end of treatment cardiotoxicity & late effects monitoring can help in comprehensive management of cardio oncology issues in Lymphoma.
Disclaimer: The Views/Opinions expressed and/or opinions provided in Videos and other content on MedEnrich Website are those of respective speakers. They do not purport to reflect the opinion or views of Dr.Reddy’s Laboratories Limited or its affiliates (collectively Dr.Reddy’s)in any manner whatsoever and accordingly ,Dr.Reddys does not recommend , endorse or make any representation about the veracity and appropriateness of the views ,opinions/ information on MedEnrich website. Content on MedEnrich website may discuss uses and dosage for therapeutic product that may not have been approved in by the relevant regulatory agencies in your country. Dr.Reddy’s does not support , endorse or encourage any off-label use. Please refer to approved label before prescribing.
